EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways

Hai-Peng Cheng, Xing-Wen Bao, Yong-Yu Luo, Yang-Hang Li, Yan Zhou, Qing-Zhong Hua, Yu-Jia Qiu, Xin-Yue Liang, Yan-Hong Huang, Wei Liu, Si-Yuan Tang, Dan-Dan Feng und 2 weitere

The International Journal of Biochemistry & Cell Biology · 2024

DOI: 10.1016/j.biocel.2024.106530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2024. Verfasst von Hai-Peng Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Respiratory Distress Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Xiangya Hospital, Central South University, National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) has a high mortality rate and incidence of complications. The pathophysiology of ALI/ARDS is still not fully understood. The lipopolysaccharide (LPS)-induced mouse model of ALI has been widely used to study human ALI/ARDS. Sulfasalazine (SASP) has antibacterial and anti-inflammatory effects and is used for treating inflammatory bowel and rheumatic diseases. However, the effect of SASP on LPS-induced ALI in mice has not yet been reported. Therefore, we aimed to investigate the effect of SASP on LPS-induced ALI in mice. Mice were intraperitoneally injected with SASP 2 h before or 4 h after LPS modeling. Pulmonary pathological damage was measured based on inflammatory factor expression (malondialdehyde and superoxide dismutase levels) in the lung tissue homogenate and alveolar lavage fluid. The production of inflammatory cytokines and occurrence of oxidative stress in the lungs induced by LPS were significantly mitigated after the prophylactic and long-term therapeutic administration of SASP, which ameliorated ALI caused by LPS. SASP reduced both the production of inflammatory cytokines and occurrence of oxidative stress in RAW264.7 cells, which respond to LPS. Moreover, its mechanism contributed to the suppression of NF-κB and nuclear translocation. In summary, SASP treatment ameliorates LPS-induced ALI by mediating anti-inflammatory and antioxidant effects, which may be attributed to the inhibition of NF-κB activation and promotion of antioxidant defenses. Thus, SASP may be a promising pharmacologic agent for ALI therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryRespiratory Distress SyndromeMiceHumansAnimalsNF-kappa BLipopolysaccharidesSulfasalazineLungOxidative StressAnti-Inflammatory AgentsCytokinesAntioxidants

Stichwörter der Autor:innen

Acute lung injuryInflammationLipopolysaccharideNF-κBSulfasalazine

Substanzen

NF-kappa BLipopolysaccharidesSulfasalazineAnti-Inflammatory AgentsCytokinesAntioxidants

Autor:innen und Institutionen

  • Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Physiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Xiangya Nursing School, Central South University, Changsha, Hunan, China.
  • Department of Physiology, Changzhi Medical College, Changzhi, Shanxi, China. Electronic address: c.li@czmc.edu.cn.
  • Department of Physiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China; Hunan Key Laboratory of Organ Fibrosis, Central South University, Changsha, Hunan, China. Electronic address: luozi…

Förderung

  • Xiangya Hospital, Central South University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Cheng, H. P., Bao, X. W., Luo, Y. Y., Li, Y. H., Zhou, Y., Hua, Q. Z., Qiu, Y. J., Liang, X. Y., Huang, Y. H., Liu, W., Tang, S. Y., Feng, D. D., Li, C., & Luo, Z. Q. (2024). Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2024.106530

Vancouver

Cheng HP, Bao XW, Luo YY, Li YH, Zhou Y, Hua QZ, et al. Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways. The International Journal of Biochemistry & Cell Biology. 2024. doi:10.1016/j.biocel.2024.106530

BibTeX
@article{Cheng2024,
  author = {Cheng, Hai-Peng and Bao, Xing-Wen and Luo, Yong-Yu and Li, Yang-Hang and Zhou, Yan and Hua, Qing-Zhong and Qiu, Yu-Jia and Liang, Xin-Yue and Huang, Yan-Hong and Liu, Wei and Tang, Si-Yuan and Feng, Dan-Dan and Li, Chen and Luo, Zi-Qiang},
  title = {Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2024},
  doi = {10.1016/j.biocel.2024.106530}
}
Kostenlos starten →